LAURA MATRANA: Open Payments
NPI 1619320520 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 28 payments from 10 companies in 2025. Trend: 2023 $520 · 2024 $609 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 5 | $241 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $155 |
| Insulet Corporation | 5 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $96 |
| Exact Sciences Corporation | 2 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| BETA BIONICS, INC. | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Sequel Med Tech, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: DEXCOM G7 GSS (161), JARDIANCE, Omnipod, Kerendia, Dexcom G6 Transmitter, Cologuard Collection Kit, Ozempic, iLet Bionic Pancreas.
Industry payments across LA — which companies pay providers there.
